science
'Transformative' pancreatic cancer drug doubles survival time
Why this matters: new research or scientific developments with potential real-world impact.
People with advanced pancreatic cancer taking an experimental daily pill lived nearly twice as long as those receiving chemotherapy infusions
Read full story on New Scientist → More top storiesAlso covered by
Bloomberg Markets
Akeso To Boost Manufacturing Of Cancer Drug
STAT News
STAT+: A turning point for pancreatic cancer patients
MarketWatch
Why doctors stood up and cheered mid-presentation for a historic pancreatic cancer treatment
MarketWatch
An experimental lung-cancer drug could replace Keytruda one day. But investors aren’t wowed.
Aggregated and edited by the Scoop newsroom. We surface news from New Scientist alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop